XBI vs. BOTZ
XBI (SPDR S&P Biotech ETF) and BOTZ (Global X Robotics & Artificial Intelligence Thematic ETF) are both exchange-traded funds - XBI is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index, while BOTZ is a Robotics fund tracking the Indxx Global Robotics & Artificial Intelligence Thematic Index. Both are passively managed. Over the past 5 years, XBI returned 0.52%/yr vs 2.06%/yr for BOTZ. A 0.57 correlation means they provide meaningful diversification when combined. XBI charges 0.35%/yr vs 0.68%/yr for BOTZ.
Performance
XBI vs. BOTZ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XBI achieves a 11.87% return, which is significantly higher than BOTZ's 5.58% return.
XBI
- 1D
- 1.95%
- 1M
- 4.37%
- YTD
- 11.87%
- 6M
- 11.41%
- 1Y
- 63.76%
- 3Y*
- 16.08%
- 5Y*
- 0.52%
- 10Y*
- 9.98%
BOTZ
- 1D
- 3.04%
- 1M
- -4.92%
- YTD
- 5.58%
- 6M
- 6.30%
- 1Y
- 24.59%
- 3Y*
- 9.30%
- 5Y*
- 2.06%
- 10Y*
- —
XBI vs. BOTZ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XBI SPDR S&P Biotech ETF | 11.87% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
BOTZ Global X Robotics & Artificial Intelligence Thematic ETF | 5.58% | 14.17% | 12.26% | 38.97% | -42.69% | 8.65% | 51.92% | 31.80% | -28.34% | 58.01% |
Correlation
The correlation between XBI and BOTZ is 0.48, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.48 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.54 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.58 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2016 | 0.57 |
The correlation between XBI and BOTZ shifts across timeframes, from 0.48 (1 year) to 0.58 (5 years), reflecting how their relationship changes across market environments.
XBI vs. BOTZ - Sectors Allocation Comparison
Sectors
XBI
BOTZ
Healthcare
Financial Services
Basic Materials
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
Healthcare
XBI
BOTZ
Financial Services
XBI
BOTZ
Basic Materials
XBI
BOTZ
Communication Services
XBI
-
BOTZ
Consumer Cyclical
XBI
-
BOTZ
Consumer Defensive
XBI
-
BOTZ
Energy
XBI
-
BOTZ
Industrials
XBI
-
BOTZ
Real Estate
XBI
-
BOTZ
-
Technology
XBI
-
BOTZ
Utilities
XBI
-
BOTZ
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XBI vs. BOTZ — Risk / Return Rank
XBI
BOTZ
XBI vs. BOTZ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XBI | BOTZ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.47 | ||
| Sortino ratioReturn per unit of downside risk | +1.78 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.18 | +0.21 |
| Calmar ratioReturn relative to maximum drawdown | 6.59 | 1.28 | +5.31 |
| Martin ratioReturn relative to average drawdown | 19.47 | 4.20 | +15.27 |
Loading charts...
Drawdowns
XBI vs. BOTZ - Drawdown Comparison
The maximum XBI drawdown since its inception was -63.89%, which is greater than BOTZ's maximum drawdown of -55.54%. Use the drawdown chart below to compare losses from any high point for XBI and BOTZ.
Loading charts...
Drawdown Indicators
| XBI | BOTZ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.89% | -55.54% | -8.35% |
Max Drawdown (1Y)Largest decline over 1 year | -9.72% | -19.34% | +9.62% |
Max Drawdown (3Y)Largest decline over 3 years | -32.99% | -29.02% | -3.97% |
Max Drawdown (5Y)Largest decline over 5 years | -54.71% | -55.54% | +0.83% |
Max Drawdown (10Y)Largest decline over 10 years | -63.89% | — | — |
Current DrawdownCurrent decline from peak | -21.16% | -8.12% | -13.04% |
Average DrawdownAverage peak-to-trough decline | -20.93% | -18.28% | -2.65% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.29% | 5.86% | -2.57% |
Volatility
XBI vs. BOTZ - Volatility Comparison
SPDR S&P Biotech ETF (XBI) has a higher volatility of 10.55% compared to Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ) at 9.53%. This indicates that XBI's price experiences larger fluctuations and is considered to be riskier than BOTZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XBI | BOTZ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.55% | 9.53% | +1.02% |
Volatility (6M)Calculated over the trailing 6-month period | 20.83% | 19.72% | +1.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.18% | 25.24% | +0.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.22% | 26.95% | +5.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.03% | 25.81% | +6.22% |
XBI vs. BOTZ - Expense Ratio Comparison
XBI has a 0.35% expense ratio, which is lower than BOTZ's 0.68% expense ratio.
Dividends
XBI vs. BOTZ - Dividend Comparison
XBI's dividend yield for the trailing twelve months is around 0.32%, less than BOTZ's 0.62% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BOTZ Global X Robotics & Artificial Intelligence Thematic ETF | 0.62% | 0.66% | 0.13% | 0.20% | 0.23% | 0.16% | 0.19% | 0.83% | 1.44% | 0.01% | 0.06% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.32% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
XBI and BOTZ have a correlation of 0.48, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBI has higher volatility (10.55%) compared to BOTZ (9.53%). In terms of maximum drawdown, XBI dropped -63.89% vs BOTZ's -55.54%.
On 5-year performance, BOTZ leads with 2.06% vs 0.52% for XBI. On fees, XBI is cheaper at 0.35% per year. On volatility, BOTZ has been the lower-risk option at 9.53%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, BOTZ has performed better with a 2.06% return vs 0.52%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XBI is cheaper with a 0.35% expense ratio, compared with 0.68% for BOTZ.
BOTZ has the higher dividend yield at 0.62%, compared with 0.32% for XBI.
XBI is categorized as Health & Biotech Equities, while BOTZ is Robotics. XBI tracks S&P Biotechnology Select Industry Index, while BOTZ tracks Indxx Global Robotics & Artificial Intelligence Thematic Index. They also come from different issuers: State Street and Global X. Their fees differ too: 0.35% for XBI and 0.68% for BOTZ.
XBI currently has the higher Sharpe Ratio (2.45 vs 0.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XBI and BOTZ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer